CytoMed Therapeutics Limited

DB:F98 Stock Report

Market Cap: €25.0m

CytoMed Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of F98?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,9150.0426%
Public Companies1,336,92311.6%
Individual Insiders2,168,67518.8%
General Public3,541,19630.7%
Private Companies4,488,29138.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 9 shareholders own 69.31% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
38.9%
Glorious Finance Ltd.
4,488,291€9.7m0%no data
11.6%
mDR Limited
1,336,923€2.9m0%no data
7.66%
Shu Wang
883,858€1.9m0%no data
5.18%
Chee Kong Choo
598,015€1.3m0%no data
5.11%
Jieming Zeng
589,239€1.3m0%no data
0.8%
Tien Wee Luk
92,563€200.8k0%no data
0.043%
Wee Kiat Tan
5,000€10.8k0%no data
0.042%
Geode Capital Management, LLC
4,854€10.5k2.99%no data
0.00053%
UBS Asset Management AG
61€132.70%no data